We are live on
!
Find out more
GAI
General American Investors Portfolio holdings
AUM
$1.69B
1-Year Est. Return
40.94%
This Fund
S&P 500
This Quarter
Est. Return
+0.74%
1 Year Est. Return
+40.94%
3 Year Est. Return
+128.91%
5 Year Est. Return
+178.43%
10 Year Est. Return
+618.93%
AUM
$1.22B
AUM Growth
+$1.65M
(+0.14%)
Cap. Flow
-$3.03M
Cap. Flow
% of AUM
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
36.59%
Holding
63
New
4
Increased
9
Reduced
9
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVNS
Avanos Medical
AVNS
|
+$7.95M |
| 2 |
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
|
+$5.97M |
| 3 |
HCBK
HUDSON CITY BANCORP INC
HCBK
|
+$4.83M |
| 4 |
VRNT
Verint Systems
VRNT
|
+$4.57M |
| 5 |
Cameco
CCJ
|
+$2.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Owens Corning
OC
|
+$9.37M |
| 2 |
FCB
FCB Financial Holdings, Inc.
FCB
|
+$4.68M |
| 3 |
IMPV
Imperva, Inc.
IMPV
|
+$4.5M |
| 4 |
DuPont de Nemours
DD
|
+$3.66M |
| 5 |
Pfizer
PFE
|
+$3.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.45% |
| 2 | Technology | 20.81% |
| 3 | Industrials | 12.89% |
| 4 | Healthcare | 12.47% |
| 5 | Consumer Staples | 8.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CEMP
51
DELISTED
Cempra, Inc.
CEMP
| $5.84M | 0.48% |
170,000
| – | – |
|
|
HCBK
52
DELISTED
HUDSON CITY BANCORP INC
HCBK
| $4.94M | 0.41% |
+500,000
| New | +$4.83M |
|
|
RPRX
53
DELISTED
Repros Therapeutics Inc.
RPRX
| $4.3M | 0.35% |
601,553
+93,178
| +18% | +$726K |
|
|
BNBX
54
DELISTED
BNB PLUS CORP
BNBX
| $3.64M | 0.3% |
2
| – | – |
|
55
Royce Value Trust
RVT
$2.3B
| $2.79M | 0.23% |
202,486
+4,090
| +2% | +$58.2K |
|
56
Adams Diversified Equity Fund
ADX
$3.2B
| $2.33M | 0.19% |
166,689
| – | – |
|
57
Herc Holdings
HRI
$5.61B
| $1.31M | 0.11% |
24,167
| – | – |
|
|
APDNW
58
DELISTED
Applied DNA Sciences Inc Warrant
APDNW
| $1.2M | 0.1% |
860,000
| – | – |
|
|
MNDT
59
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $489K | 0.04% |
+10,000
| New | +$453K |
|
|
60
DuPont de Nemours
DD
$19.2B
| – | – |
-30,129
| Closed | -$3.66M |
|
|
IMPV
61
DELISTED
Imperva, Inc.
IMPV
| – | – |
-105,300
| Closed | -$4.5M |
|
Similar funds
PP
BCM
GAM
FACM
RSCM
ACM
RMC
JIP
General American Investors's Q2 2015 Portfolio in Review
As of Q2 2015, General American Investors held 63 positions worth $1.22B, up 0.14% from $1.22B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
General American Investors's Q2 2015 filing shows 4 new, 9 increased, 9 reduced and 2 closed positions. Its largest new stake was Avanos Medical: 177,119 shares worth $7.17M. The largest sale was Owens Corning, an estimated $9.37M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.
- General American Investors's largest Q2 2015 buy was Avanos Medical: 177,119 shares worth $7.17M.
- General American Investors added most to Paratek Pharmaceuticals, Inc. in Q2 2015, an estimated $5.97M increase.
- General American Investors's biggest Q2 2015 reduction was Owens Corning, cutting an estimated $9.37M.
- General American Investors fully exited Imperva, Inc. in Q2 2015, selling an estimated $4.5M.
- General American Investors's ten largest holdings make up 37% of its $1.22B portfolio in Q2 2015.
- General American Investors opened 4 new positions and closed 2 in Q2 2015.
- General American Investors's portfolio value rose 0.14% quarter-over-quarter to $1.22B.
Based on General American Investors's 13F filing for Q2 2015, filed 3 Aug 2015.